Beck, E
Key Takeaways Over 80 peptide drugs are FDA-approved worldwide and 170+ are in active clinical development the fastest-growing drug class in pharma Therapeutic peptides cover tissue repair, metabolic, cognitive, immune, and mitochondrial categories each with distinct mechanisms and research applications BPC-157, TB-500, and Thymosin Alpha-1 returned to Category 1 compounding status in February 2026 after the HHS reclassification Next-gen metabolic peptides like Retatrutide (triple agonist) showed up to 24.2% body weight reduction in Phase 2 the highest ever recorded The global peptide therapeutics market exceeded $140 billion in 2025 and is projected to nearly double by 2033 Therapeutic peptides are short amino acid chains (2-50 residues) used in clinical research and approved medicine
If your compounded tirzepatide was exposed to temperatures above 86 degrees Fahrenheit, even for a few hours, the degradation rate accelerates dramatically
Validity Period Verification Process Accelerated test Condition: 402/75%RH5%RH for 6 consecutive months
Research Context Cagrilintide is a peptide derived from the GLP-2 receptor agonist class, originally developed to explore its effects on gastrointestinal function and nutrient absorption
Pollen bee aqueous extract-based synthesis of silver nanoparticles and evaluation of their anti-cancer and anti-bacterial activities